Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Saccharomyces cerevisiae and Improved Intestinal Barrier Function

Research synthesisLow evidenceMixed effect size3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects of Saccharomyces cerevisiae-based interventions on intestinal barrier function, with effect sizes ranging from moderate to large, and 2 of 3 findings were statistically significant. Most often assessed in animal models (broilers, aging mice) and in vitro cell systems, with no consistent dose or duration data extracted across studies.

  • Studied populations: broiler chickens, D-galactose-induced aging mouse model, LPS-stimulated Caco-2 cell line

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. All studies are in non-human populations (animals or cell lines); relevance to human intestinal barrier function is uncertain. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Two of three studies lacked evidence scores and comprehensive methodological reporting.

Generated Jun 11, 2026
5 of 5 papers
Back to top